EUVIMEDEUVIMED entdecken
Crossref

Gold-nanocube-based SERS sensor for accurate detection of Alzheimer's disease biomarkers: Aβ42 and MAO-B

Chenchen Wang, Xiaolei Song, Diantao Chen, Junyu Su, Yong Wang, Cheng Huang, Wei Wei

Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy · 2026-12 · 362 · 128185

DOI: 10.1016/j.saa.2026.128185 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy, 2026-12. Verfasst von Chenchen Wang und 6 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmaceutical and Chemical Engineering, Southeast University Chengxian College, Nanjing 210088, PR China; Key Laboratory of Environmental …. Hauptthemen laut MEDLINE: Amyloid beta-Peptides, Alzheimer Disease, Spectrum Analysis, Raman, Gold. Die Arbeit nennt 42 Literaturangaben. Gefördert von: Major Basic Research Project of the Natural Science Foundation of the Jiangsu Higher Education Institutions, National Natural Science Foundation of China, Natural Science Foundation of Jiangsu Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Considering the irreversible nature of Alzheimer's disease (AD), early diagnosis is of great importance for AD treatment. Both β-amyloid (Aβ) and monoamine oxidase B (MAO-B) are potential biomarkers for AD. This study developed a surface-enhanced Raman scattering (SERS) sensor using gold-nanocube (OX-AuNCs) to detect Aβ42 and MAO-B. OX-AuNCs, a type of gold-nanocube with open gaps, achieved a Raman enhancement factor of 8.99 × 108 due to numerous hot spots. The specific affinity between Thioflavin T (ThT) and Aβ42 inhibits ThT's intramolecular rotation, reducing its SERS signal. This reduced signal showed a linear correlation with Aβ42 concentrations from 66.70 pM to 0.20 μM, achieving a limit of detection (LOD) at 44.30 pM, while also distinguishing different aggregation levels of Aβ42. Interestingly, SERS intensity of phenethylamine (PEA) also decreased significantly when interacting with MAO-B. A linear relationship was found between the change in PEA intensity and MAO-B concentration (0.01-20.00 μg mL-1), yielding an LOD of 5.00 ng mL-1. The proposed SERS sensor effectively detected two potential AD biomarkers, Aβ42 and MAO-B, in artificial cerebrospinal fluid (ACSF) and human serum with satisfactory recovery rates, respectively. These results show promise for clinical diagnosis and drug screening for AD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Amyloid beta-PeptidesAlzheimer DiseaseSpectrum Analysis, RamanGoldMonoamine OxidaseMetal NanoparticlesPeptide FragmentsHumansBiomarkersLimit of Detection

Stichwörter der Autor:innen

Alzheimer's diseaseEarly diagnosisMonoamine oxidase BSERS sensorβ-amyloid

Substanzen

Amyloid beta-PeptidesGoldMonoamine OxidaseBiomarkersamyloid beta-protein (1-42)Peptide Fragments

Autor:innen und Institutionen

  • School of Pharmaceutical and Chemical Engineering, Southeast University Chengxian College, Nanjing 210088, PR China; Key Laboratory of Environmental Medicine Engineering of Ministry of Education, School of Chemistry and…
  • Key Laboratory of Environmental Medicine Engineering of Ministry of Education, School of Chemistry and Chemical Engineering, Southeast University, Nanjing 210009, PR China.
  • Institute of Forensic Science and Technology of Nanjing Public Security Bureau, Nanjing 210001, China.
  • School of Pharmaceutical and Chemical Engineering, Southeast University Chengxian College, Nanjing 210088, PR China.
  • Key Laboratory of Environmental Medicine Engineering of Ministry of Education, School of Chemistry and Chemical Engineering, Southeast University, Nanjing 210009, PR China. Electronic address: weiw@seu.edu.cn.

Förderung

  • Major Basic Research Project of the Natural Science Foundation of the Jiangsu Higher Education Institutions
  • National Natural Science Foundation of China
  • Natural Science Foundation of Jiangsu Province

Zitieren

APA

Wang, C., Song, X., Chen, D., Su, J., Wang, Y., Huang, C., & Wei, W. (2026). Gold-nanocube-based SERS sensor for accurate detection of Alzheimer's disease biomarkers: Aβ42 and MAO-B. Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy, 362, 128185. https://doi.org/10.1016/j.saa.2026.128185

Vancouver

Wang C, Song X, Chen D, Su J, Wang Y, Huang C, et al. Gold-nanocube-based SERS sensor for accurate detection of Alzheimer's disease biomarkers: Aβ42 and MAO-B. Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy. 2026;362:128185. doi:10.1016/j.saa.2026.128185

BibTeX
@article{Wang2026,
  author = {Wang, Chenchen and Song, Xiaolei and Chen, Diantao and Su, Junyu and Wang, Yong and Huang, Cheng and Wei, Wei},
  title = {Gold-nanocube-based SERS sensor for accurate detection of Alzheimer's disease biomarkers: Aβ42 and MAO-B},
  journal = {Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy},
  year = {2026},
  volume = {362},
  pages = {128185},
  doi = {10.1016/j.saa.2026.128185}
}
Kostenlos starten →